-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Avalo Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2024.
- Avalo Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2024 was -503 %, a 65.1% increase year-over-year.
- Avalo Therapeutics, Inc. annual Return On Equity for 2024 was -503 %, a 65.1% increase from 2023.
- Avalo Therapeutics, Inc. annual Return On Equity for 2023 was -1.44K %, a 208% decline from 2022.
- Avalo Therapeutics, Inc. annual Return On Equity for 2022 was 1.33K %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)